What initial antihypertensive therapy should be started in an adult with newly diagnosed essential hypertension and alcohol‑use disorder who has blood pressure ≥160/100 mmHg after lifestyle modification?

Initial Antihypertensive Therapy for Stage 2 Hypertension with Alcohol-Use Disorder

Start amlodipine 5 mg once daily immediately, combined with intensive lifestyle modification focused on alcohol cessation and sodium restriction to <2 g/day. 1

Rationale for Amlodipine as First-Line Therapy

• Amlodipine provides true 24-hour blood pressure control with once-daily dosing, maintaining effective blood levels throughout the entire dosing interval without tolerance development during long-term use. 2, 3, 4
• For a patient with BP ≥160/100 mmHg (stage 2 hypertension), immediate pharmacologic therapy is mandatory rather than a trial of lifestyle modification alone; the 2017 ACC/AHA guideline gives this a Class I recommendation. 1
• Calcium channel blockers are particularly appropriate in patients with alcohol-use disorder because they do not interact adversely with alcohol, unlike beta-blockers or centrally-acting agents, and they maintain efficacy regardless of volume status. 1, 3
• Amlodipine produces mean blood pressure reductions of approximately 23/13 mmHg at therapeutic doses, which is sufficient to bring many stage 2 patients to goal with monotherapy. 3

Dosing Strategy

• Begin with amlodipine 5 mg once daily in the morning; this is the most appropriate starting dose based on dose-ranging studies. 2, 3
• Reassess blood pressure within 1 month (Class I recommendation for stage 2 hypertension), and if BP remains ≥140/90 mmHg, increase to amlodipine 10 mg once daily. 1, 2
• Amlodipine reaches steady-state blood levels and maximal antihypertensive effect within 2–4 weeks, so dose adjustments should not occur more frequently. 3, 4

Critical Lifestyle Interventions (Mandatory, Not Optional)

• Alcohol cessation is the single most important intervention in this patient; regular alcohol use raises blood pressure in treated hypertensive subjects by approximately 5/3 mmHg, and curtailing intake improves blood pressure control independently of weight changes. 5, 6
• In men, any alcohol intake ≥1 drink per day significantly increases hypertension risk, with a threshold of ≥4 drinks per day showing particularly deleterious effects. 6
• Sodium restriction to <2 g/day yields an additional 5–10 mmHg systolic reduction and enhances the efficacy of all antihypertensive classes, including calcium channel blockers. 1
• Weight loss (if BMI ≥25 kg/m²) produces approximately 6/4.6 mmHg reduction per 10 kg lost. 1
• DASH dietary pattern reduces BP by approximately 11.4/5.5 mmHg. 1
• Regular aerobic exercise (≥150 minutes/week) lowers BP by approximately 4/3 mmHg. 1

When to Add a Second Agent

• If BP remains ≥140/90 mmHg after 4 weeks on amlodipine 10 mg, add either an ACE inhibitor (lisinopril 10 mg daily) or a thiazide-like diuretic (chlorthalidone 12.5–25 mg daily) to create guideline-recommended dual therapy. 1, 7
• Chlorthalidone is preferred over hydrochlorothiazide due to its longer duration of action (24–72 hours vs 6–12 hours) and superior cardiovascular outcome data. 1, 7, 8
• The combination of amlodipine + ACE inhibitor or amlodipine + thiazide diuretic produces important additional antihypertensive effects beyond monotherapy dose escalation. 2, 3

Blood Pressure Targets

• Primary target: <130/80 mmHg for most adults. 1
• Minimum acceptable target: <140/90 mmHg. 1
• Achieve target within 3 months of therapy initiation. 1

Monitoring Plan

• Reassess BP within 1 month after starting amlodipine (Class I recommendation for stage 2 hypertension). 1
• Check serum potassium and creatinine 2–4 weeks after adding a thiazide diuretic (if needed) to detect hypokalemia or renal impairment. 1, 7, 8
• Confirm control with home BP monitoring (target <135/85 mmHg) or 24-hour ambulatory monitoring (target <130/80 mmHg). 1

Escalation to Triple Therapy (If Needed)

• If BP remains ≥140/90 mmHg on dual therapy, add the third agent from the remaining class to form the standard triple regimen: amlodipine + ACE inhibitor + thiazide diuretic. 1, 7
• This triple combination targets three complementary mechanisms—vasodilation, renin-angiotensin blockade, and volume reduction—and achieves control in >80% of patients. 1, 7

Critical Pitfalls to Avoid

• Do not delay pharmacologic therapy in a patient with BP ≥160/100 mmHg; stage 2 hypertension requires immediate treatment to reduce cardiovascular risk. 1
• Do not use beta-blockers as first-line therapy unless there are compelling indications (angina, post-MI, heart failure, atrial fibrillation); beta-blockers are less effective than calcium channel blockers for stroke prevention and may worsen metabolic parameters in patients with alcohol-use disorder. 1
• Do not assume lifestyle modification alone will suffice; while alcohol cessation is critical, this patient's BP is too high to withhold medication. 1, 5
• Do not combine an ACE inhibitor with an ARB (dual RAS blockade), as this increases adverse events without added benefit. 1, 7